bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Time to Buy?

bioMerieux (OTCMKTS:BMXMF) shares gapped up prior to trading on Thursday. The stock had previously closed at $95.00, but opened at $99.55. bioMerieux shares last traded at $99.55, with a volume of 32 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on BMXMF shares. Zacks Research upgraded bioMerieux from a “strong sell” rating to a “hold” rating in a research report on Monday, September 28th. Morgan Stanley restated an “underweight” rating on shares of bioMerieux in a research report on Friday, September 11th. Five analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce”.

bioMerieux Stock Performance

The company has a 50-day moving average of $88.01 and a two-hundred day moving average of $86.11.

bioMerieux Company Profile

bioMérieux is a France-based company specializing in in vitro diagnostics. It develops and manufactures diagnostic systems, reagents, software and services used to detect disease, identify infectious organisms and support treatment decisions. Its offerings serve hospitals, clinical laboratories and other healthcare providers, with a particular focus on infectious diseases, antimicrobial resistance and syndromic testing.

The company also provides industrial microbiology solutions for applications such as food safety, pharmaceutical manufacturing and quality control.